MIAVR benefits to patients with obesity and COPD

Responsive image

MIAVR in obese patients may result in lower mortality and lower morbidity compared with FS1 Learn more ....

  • Reduced morbidity resulted in a decreased intensive care and hospital stay1
  • The conversion rate to full sternotomy was 2.6–4.0%, indicating that there was good exposure in obese patients1
expand

Clinical outcomes in obese patients1

Responsive image

for MIAVR, chest wall continuity is maintained, so it is beneficial for patients with COPD2**

Subscribe to our MIAVR Deep-Dive Newsletter (3 news during 3 months)

Visit Edwards Masters – our professional education website

See previous chapter

MIAVR provides benefits to patients and surgeons

See next chapter

What are the limitations of MIAVR?

References 

AVR, Aortic Valve Replacement; FS, Full Sternotomy; MIS, Minimally Invasive Surgery; MIAVR, Minimally Invasive Aortic Valve Replacement; RDAVR, Rapid Deployment* Aortic Valve Replacement; COPD, Chronic Obstructive Pulmonary Disease

* Simplified implantation through reduced suture steps

  1. Santana O et al. Ann Thorac Surg. 2011;91:406–410.
  2. Fukukawa N European Journal of Cardio-Thoracic Surgery. 2014;46:221–227.

Edwards, Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation or its affiliates. All the other trademarks are the property of their respective owners. 

© 2018 Edwards Lifesciences Corporation. All rights reserved. E6713/03-18/HVT

Edwards Lifesciences • Route de l’Etraz 70, 1260 Nyon, Switzerland • edwards.com/eu

Subscribe here